Affimed N.V. (AFMD) Fundamentals

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.
SHARE INFORMATION
Market Cap$ 307,639,030
Shares Outstanding149,339,335
Float144,454,745
Percent Float96.73%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 45,912,086
Latest Fiscal EPS$ -0.55
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions291
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months11,133,979
Institutional Holdings Percent68.1%
Institutional Sold Previous 3 Months8,622,287
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 7.35
52 Week Low$ 1.93
52 Week High Change$ -66.67
21 Day Moving Average$ 2.3324
21 Day Extended Moving Average$ 2.2935
50 Day Moving Average$ 2.718
50 Day Extended Moving Average$ 2.5887
200 Day Moving Average$ 3.6372
200 Day Extended Moving Average$ 3.6504
10 Day Average Volume1,070,939
20 Day Average Volume1,380,555
30 Day Average Volume1,216,309
50 Day Average Volume1,051,953
Alpha0.020840
Beta2.2996
Standard Deviation0.342474
R20.114791
7 Day Price Change$ 0.06
7 Day Percent Change3.0%
21 Day Price Change$ -0.68
21 Day Percent Change-24.82%
30 Day Price Change$ -0.56
30 Day Percent Change-21.37%
Month to Date Price Change$ -0.56
Month to Date Percent Change-21.37%
Quarter to Date Price Change$ -0.71
Quarter to Date Percent Change-25.63%
180 Day Price Change$ -2.31
180 Day Percent Change-52.86%
200 Day Price Change$ -2.15
200 Day Percent Change-51.07%
Year to Date Price Change$ -3.46
Year to Date Percent Change-62.68%

Affimed N.V. (AFMD) Key Ratios

PROFITABILITY
EBIT Margin-218.8%
EBITDA Margin-214.7%
Pre-Tax Profit Margin-457.3%
Profit Margin Count-93.14%
Gross Margin0.0%
Profit Margin TOT-93.14%
INCOME STATEMENTS
Revenue$ 27,194,746
Revenue Per Share$ 0.1821
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.50
Total Debt To Equity0.10
Int Coverage-63.10
Current Ratio4.90
Leverage Ratio1.50
Quick Ratio4.70
Long Term Debt To Capital0.07
VALUATION MEASURES
PE Ratio-3.10
Enterprise Value$ 92,940,502
Price to Sales11.3124
Price to Free Cash-3.40
PE High Last 5 Years-2.90
Price To Book1.60
Price To Cash Flow2.00
PE Low Last 5 Years-7.90
Price to Tangible Book1.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.60
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-29.97
Return on Equity-44.37
Return on Capital-40.43

Affimed N.V. (AFMD) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG AG Wirtschaftspruefungsgesellschaft
CEOAdi Hoess
Emplyoees197
Last AuditUQ
CIK0001608390
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
AddressIm Neuenheimer Feld 582
Technologiepark
Heidelberg, BW 69120
Websitehttps://www.affimed.com
Facsimile+49 62216743649
Telephone+49 6221674360
Emailir@affimed.com


Your Recent History
NASDAQ
AFMD
Affimed NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.